U.S. to Narrow Opioid Bribe Case Against Insys Founder, Others

By REUTERS
NYT
U.S. prosecutors on Tuesday said they will narrow a case against several former Insys Therapeutics Inc executives accused of bribing doctors to prescribe a potent opioid after a federal judge questioned the scope of the indictment charging them.
Published date: July 24, 2018 at 08:27PM
Reuters
New York Times article